Alan Baldridge
MD, Senior Director, Gastroenterology and Hepatology, Drug Development Solutions ICON
Dr. Alan Baldridge is a board-certified Pediatric Gastroenterologist and Pediatrician working in pharmaceutical drug development. He joined ICON in 2020 as a Medical Director and switched to the role of Senior Development Director in 2022. His current role involves medical monitoring and safety management where he assesses regulatory reporting requirements and reviews notification letters to regulators, whilst also providing analysis and summaries to regulatory bodies, IRBs and/or ethics committees. He is licensed with the State Bar of Michigan and the Board of Medicine in Minnesota.
Seminars
This session discusses moving beyond GLP-1 RA therapy for drug developers. It will begin with an overview of current GLP 1 RA applications and a discussion of outcomes reported patients treated with GLP-1s. The session will then examine key considerations for developing next generation metabolic therapies, supported by examples from recent drug development programs.
